Nephritis is a kidney related disease caused by lupus. Nephritis is a serious type of problem that cause inflammation or swelling of the glomerulus. This inflammation lowers the kidney’s ability to riddle waste from the human blood. The other commonly used abbreviation for nephritis is glomerulonephritis. The major cause of nephritis is due to bad immune system of the body. Certain drugs and substances which do not suit the body often damage the kidneys and also lower the body’s immune system. The basic symptoms of nephritis may include weight gain, dark urine, high blood pressure, frothy urine, vomiting, high fever, pain in the pelvis, and frequent need to urinate. Nephritis may vary from a non-damaging or mild condition to a significant problem causing kidney failure. Nephritis may be often narrated as chronic or acute. The acute form suddenly develops after a throat or skin infection. Treatment of such infections is done using antibiotics to prevent them from causing harm to the kidney. Chronic nephritis silently develops over a long period of time and can lead to kidney failure. There are several types of nephritis which may include focal nephritis, diffuse nephritis, and nephrotic syndrome. Factors such as age and characteristic of urine is often used to diagnose type of nephritis. Nephritis often causes kidney failure and therefore tests like blood test, kidney biopsy, ultrasound and Magnetic Resonance Imaging (MRI) or Computerized Tomography (CT) are often conducted to detect nephritis.
Rising number of people suffering from kidney problems, creates a huge demand for nephritis medicines. Growing cases of nephritis and rising awareness among patients to recover from these diseases, is expected to generate high growth opportunity for nephritis treatment medicines market during the projection period. Moreover, launch of advanced biologic drugs by key market players, is expected to contribute towards the market growth. Medicines that are used for the treatment for nephritis include corticosteroids, immunosuppressive drugs and other drugs to prevent low blood pressure and blood clots. Additionally, nephritis education program launched in some countries across the globe by state health departments and voluntary health agencies to decrease the level of kidney related disease, is further expected to make the nephritis treatment medicines market more demanding over the next eight years.
The nephritis treatment medicines market in report is segmented by types which includes corticosteroids and immunosuppressive drugs.The global hypertension medications market has been moreover segmented geographically into North America, Europe, Asia-Pacific, Middle East and Africa and Latin America.
Product innovation and high investment made by leading key vendors, thereby enhances the market growth of nephritis medicines. Moreover, leading key vendors R&D activities is also expected to forecast high growth opportunity for nephritistreatment medicines market. High demand of corticosteroid drugs and immunosuppressive drugs such as, cyclophosphamide, mycophenolate and azathioprine to decrease inflammation caused by nephritis and suppress the immune system of the body respectively, therefore propels the growth of the nephritis medicines market during the forecast period of 2017-2025.
Some of the major players in the global nephritis treatment medicines marketincludeGlaxoSmithKline PLC, AstraZeneca, Roche Holding AG and few others.
Global Nephritis Treatment Medicines Market: By Type
Global Nephritis Treatment Medicines Market: By Geography